Note: Ingredients listed on restricted chemical lists
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
N/A
General Information
Product name
Ritonavir Tablets
Chemical name
Ritonavir
1.2.1 Relevant identified uses
Ritonavir tablets are an HIV protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection
supplier name
West-Ward Pharmaceuticals Corp
Icons in SDS
Company Information
company name
West-Ward Pharmaceuticals Corp
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319, H351
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200).
2.1 Classification of the substance or mixture
SERIOUS EYE DAMAGE/ EYE IRRITATION - Category 2A CARCINOGENICITY - Category 2
Signal word
Warning
Hazard statements
H319 - Causes serious eye irritation. H351 - Suspected of causing cancer. This is a pharmaceutical product designed to be prescribed by a licensed health care professional. Should any person while using this product observe any adverse health effects, they should seek medical treatment.
Prevention
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves. Wear eye or face protection. Wear protective clothing. P264 - Wash hands thoroughly after handling.
Response
P308 + P313 - IF exposed or concerned: Get medical attention. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical attention.
Storage
P405 - Store locked up.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
2.3 Other hazards
None known.
